1. Home
  2. PMAX vs ANEB Comparison

PMAX vs ANEB Comparison

Compare PMAX & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • ANEB
  • Stock Information
  • Founded
  • PMAX 2019
  • ANEB 2020
  • Country
  • PMAX Hong Kong
  • ANEB United States
  • Employees
  • PMAX N/A
  • ANEB N/A
  • Industry
  • PMAX
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMAX
  • ANEB Health Care
  • Exchange
  • PMAX Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • PMAX 6.9M
  • ANEB 111.8M
  • IPO Year
  • PMAX 2024
  • ANEB 2021
  • Fundamental
  • Price
  • PMAX $2.59
  • ANEB $2.75
  • Analyst Decision
  • PMAX
  • ANEB Buy
  • Analyst Count
  • PMAX 0
  • ANEB 2
  • Target Price
  • PMAX N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • PMAX 1.5M
  • ANEB 27.5K
  • Earning Date
  • PMAX 09-23-2025
  • ANEB 11-12-2025
  • Dividend Yield
  • PMAX N/A
  • ANEB N/A
  • EPS Growth
  • PMAX N/A
  • ANEB N/A
  • EPS
  • PMAX N/A
  • ANEB N/A
  • Revenue
  • PMAX $4,799,100.00
  • ANEB N/A
  • Revenue This Year
  • PMAX N/A
  • ANEB N/A
  • Revenue Next Year
  • PMAX N/A
  • ANEB N/A
  • P/E Ratio
  • PMAX N/A
  • ANEB N/A
  • Revenue Growth
  • PMAX N/A
  • ANEB N/A
  • 52 Week Low
  • PMAX $1.87
  • ANEB $0.80
  • 52 Week High
  • PMAX $31.92
  • ANEB $3.42
  • Technical
  • Relative Strength Index (RSI)
  • PMAX 62.51
  • ANEB 64.14
  • Support Level
  • PMAX $2.61
  • ANEB $2.50
  • Resistance Level
  • PMAX $3.07
  • ANEB $2.85
  • Average True Range (ATR)
  • PMAX 0.56
  • ANEB 0.15
  • MACD
  • PMAX -0.00
  • ANEB 0.04
  • Stochastic Oscillator
  • PMAX 46.59
  • ANEB 83.87

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: